Todenhöfer T - Search Results

1

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria.

Hennenlotter J, Huber S, Todenhöfer T, Kuehs U, Schilling D, Aufderklamm S, Gakis G, Schwentner C, Stenzl A. Hennenlotter J, et al. Among authors: todenhofer t. Adv Urol. 2011;2011:937561. doi: 10.1155/2011/937561. Epub 2011 Nov 22. Adv Urol. 2011. PMID: 22162681 Free PMC article.

2

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.

Gakis G, Todenhöfer T, Renninger M, Schilling D, Sievert KD, Schwentner C, Stenzl A. Gakis G, et al. Among authors: todenhofer t. BJU Int. 2011 Dec;108(11):1800-5. doi: 10.1111/j.1464-410X.2011.10234.x. Epub 2011 Apr 20. BJU Int. 2011. PMID: 21507193

3

The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer.

Gakis G, Todenhöfer T, Stenzl A. Gakis G, et al. Among authors: todenhofer t. Curr Opin Urol. 2011 Sep;21(5):428-33. doi: 10.1097/MOU.0b013e32834966fa. Curr Opin Urol. 2011. PMID: 21730850 Review.

4

Urethral ultrasound as a screening tool for stricture recurrence after oral mucosa graft urethroplasty.

Seibold J, Werther M, Alloussi S, Todenhöfer T, Gakis G, Aufderklamm S, Schilling D, Stenzl A, Schwentner C. Seibold J, et al. Among authors: todenhofer t. Urology. 2011 Sep;78(3):696-700. doi: 10.1016/j.urology.2011.04.051. Epub 2011 Jul 13. Urology. 2011. PMID: 21741691

5

Thymidine kinase and cancer monitoring.

Aufderklamm S, Todenhöfer T, Gakis G, Kruck S, Hennenlotter J, Stenzl A, Schwentner C. Aufderklamm S, et al. Among authors: todenhofer t. Cancer Lett. 2012 Mar;316(1):6-10. doi: 10.1016/j.canlet.2011.10.025. Epub 2011 Nov 6. Cancer Lett. 2012. PMID: 22068047 Review.

6

Influence of renal excretory function on the performance of urine based markers to detect bladder cancer.

Todenhöfer T, Hennenlotter J, Witstruk M, Gakis G, Aufderklamm S, Kuehs U, Stenzl A, Schwentner C. Todenhöfer T, et al. J Urol. 2012 Jan;187(1):68-73. doi: 10.1016/j.juro.2011.09.023. Epub 2011 Nov 16. J Urol. 2012. PMID: 22088333

7

Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma.

Todenhöfer T, Hennenlotter J, Tews V, Gakis G, Aufderklamm S, Kuehs U, Stenzl A, Schwentner C. Todenhöfer T, et al. Urol Oncol. 2013 Oct;31(7):1148-54. doi: 10.1016/j.urolonc.2011.10.011. Epub 2011 Nov 29. Urol Oncol. 2013. PMID: 22130125

8

Personalized treatment of prostate cancer based on inherited variations of steroid pathway-related genes.

Todenhöfer T, Schwentner C, Stenzl A. Todenhöfer T, et al. Eur Urol. 2012 Jul;62(1):97-9. doi: 10.1016/j.eururo.2011.12.052. Epub 2012 Jan 3. Eur Urol. 2012. PMID: 22226581 No abstract available.

9

Current status of molecular markers for prognostication and outcome in invasive bladder cancer.

Gakis G, Schwentner C, Todenhöfer T, Stenzl A. Gakis G, et al. Among authors: todenhofer t. BJU Int. 2012 Jul;110(2):233-7. doi: 10.1111/j.1464-410X.2011.10839.x. Epub 2012 Jan 11. BJU Int. 2012. PMID: 22233187 Review.

10

Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer.

Todenhöfer T, Hennenlotter J, Kühs U, Tews V, Gakis G, Aufderklamm S, Stenzl A, Schwentner C. Todenhöfer T, et al. Urology. 2012 Mar;79(3):620-4. doi: 10.1016/j.urology.2011.10.067. Urology. 2012. PMID: 22386412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters